JCN Newswire Read More Eisai to Present Data on Oncology Pipeline and Products at ASCO Annual Meeting ruth 20 5 月 3 minutes TOKYO, May 20, 2021 – (J […]
JCN Newswire Read More Eisai: European Medicines Agency Accepts the Marketing Authorisation Applications for Two Additional Indications of Anti Cancer Agent Lenvatinib in Combination with Pembrolizumab ruth 30 3 月 4 minutes TOKYO, Mar 30, 2021 – (J […]
